Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Sheng Li Xue Bao ; 64(6): 651-6, 2012 Dec 25.
Article in Chinese | MEDLINE | ID: mdl-23258328

ABSTRACT

The present study aims to explore the possible mechanisms that trichostatin A (TSA), a histone deacetylases inhibitor (HDACi), affects the inflammatory signaling pathways of lipopolysaccharide/toll-like receptor 4/nuclear factor-κB (LPS/TLR4/NF-κB). Murine macrophage cell line RAW264.7 cells were employed. MTT assay was used to assess cell viability. The contents of TNF-α, IL-1ß and IL-6 in culture supernatant were assayed by enzyme-linked immunosorbent assay (ELISA). TLR4 expression and NF-κB/p65 (Lys310) acetylation were examined by Western blotting. DNA binding activity of NF-κB/p65 was detected by using TransAM(TM) NF-κB/p65 activity assay kit. The results showed that, compared with control group, which was treated by DMSO, the cells treated with TSA (20, 40, 80 ng/mL) showed decreased percentages of cell survival (P < 0.05). The contents of TNF-α, IL-1ß and IL-6 in culture supernatant were all increased by LPS (100 ng/mL), whereas reduced by 40 ng/mL TSA pretreatment (P < 0.05). TSA pretreatment inhibited LPS-induced up-regulation of TLR4 protein expression. Acetylation of NF-κB/p65(Lys310), which was already increased by LPS, was further enhanced by TSA (P < 0.05). On the contrary, LPS-increased DNA binding activity of NF-κB/p65 was decreased by pretreatment with TSA (P < 0.05). The results suggest that TSA-induced anti-inflammation may be attributed to decreases in the expression of TLR4 and DNA binding activity of NF-κB/p65.


Subject(s)
Hydroxamic Acids/pharmacology , Macrophages/drug effects , Toll-Like Receptor 4/metabolism , Transcription Factor RelA/metabolism , Acetylation , Animals , Cell Line , Inflammation/metabolism , Interleukin-1beta/metabolism , Interleukin-6/metabolism , Lipopolysaccharides , Macrophages/metabolism , Mice , Signal Transduction , Tumor Necrosis Factor-alpha/metabolism , Up-Regulation
2.
Zhejiang Da Xue Xue Bao Yi Xue Ban ; 38(4): 377-82, 2009 Jul.
Article in Chinese | MEDLINE | ID: mdl-19693975

ABSTRACT

OBJECTIVE: To investigate the effect of ethyl acetate extract from Chrysanthemum Morifolium Ramat (CME) on experimental arrhythmia induced by ischemia/reperfusion or aconitine in rats and to explore its underlying mechanisms. METHODS: Arrhythmia model in intact rat was induced by aconitine (30 microg/kg body weight, i.v.). In isolated Langendorff perfused rat hearts, regional ischemia and reperfusion was induced by ligation and release of left anterior descending artery. The ventricular fibrillation threshold (VFT), effective refractory period (ERP), and diastolic excitation threshold (DET) in the isolated heart were measured. The action potentials of papillary muscle in rat right ventricle were recorded by conventional glass microelectrode technique. RESULTS: Compared with control group CME significantly decreased the number and duration of ventricular tachycardia (VT); delayed the occurrence of ventricular premature beats (VPB) and VT induced by aconitine. Arrhythmia score of the CME group was lower than that in aconitine-treated group. CME markedly prolonged the ERP and increased the VFT in the isolated perfused rat hearts during ischemia and reperfusion. CME prolonged action potential duration at 50% and 90% repolarization of the right ventricular papillary muscles and decreased the maximal rate of rise of the action potential upstroke, but did not affect the resting potential, amplitude of action potential. CONCLUSION: CME can reduce myocardial vulnerability and exerts its antiarrhythmic effects induced by aconitine or ischemia/reperfusion, which may be related to its prolongation of action potential duration and effective refractory period that enhance the electrophysiological stability of myocardiaium.


Subject(s)
Anti-Arrhythmia Agents/pharmacology , Arrhythmias, Cardiac/physiopathology , Chrysanthemum/chemistry , Drugs, Chinese Herbal/pharmacology , Acetates/chemistry , Action Potentials/drug effects , Animals , Anti-Arrhythmia Agents/isolation & purification , Arrhythmias, Cardiac/chemically induced , In Vitro Techniques , Male , Rats , Rats, Sprague-Dawley , Refractory Period, Electrophysiological/drug effects
3.
Neurosci Lett ; 438(1): 116-20, 2008 Jun 13.
Article in English | MEDLINE | ID: mdl-18467029

ABSTRACT

Oxidative stress is believed to contribute to neuronal damage induced by cerebral ischemia/reperfusion (I/R) injury. The present study was undertaken to evaluate the possible antioxidant neuroprotective effect of genistein against neuronal death in hippocampal CA1 neurons following transient global cerebral ischemia in the rat. Transient global cerebral ischemia was induced in male Sprague-Dawley rats by four-vessel-occlusion for 10min. At various times of reperfusion, the histopathological changes and the levels of mitochondria-generated reactive oxygen species (ROS), malondialdehyde (MDA), cytosolic cytochrome c and caspase-3 activity in hippocampus were measured. We found extensive neuronal death in the CA1 region at day 5 after I/R. The ischemic changes were preceded by increases in ROS generation and MDA concentration and followed by increased cytosolic cytochrome c, and subsequently caspase-3 activation and apoptosis. Treatment with genistein (15mg/kg, i.p.) significantly attenuated ischemia-induced neuronal death. Genistein administration also decreased ROS generation, MDA concentration and the apoptotic indices. These results suggest that genistein protects neurons from transient global cerebral I/R injury in rat hippocampus by attenuating oxidative stress, lipid peroxidation and the signaling cascade leading to apoptotic cell death.


Subject(s)
Brain Ischemia/drug therapy , Cerebral Infarction/drug therapy , Genistein/pharmacology , Nerve Degeneration/drug therapy , Oxidative Stress/drug effects , Animals , Antioxidants/pharmacology , Apoptosis/drug effects , Apoptosis/physiology , Brain Ischemia/metabolism , Brain Ischemia/physiopathology , Caspase 3/metabolism , Cerebral Infarction/metabolism , Cerebral Infarction/physiopathology , Cytochromes c/metabolism , Disease Models, Animal , Down-Regulation/drug effects , Down-Regulation/physiology , Lipid Peroxidation/drug effects , Lipid Peroxidation/physiology , Male , Malondialdehyde/metabolism , Nerve Degeneration/physiopathology , Nerve Degeneration/prevention & control , Neuroprotective Agents/pharmacology , Oxidative Stress/physiology , Protein Kinase Inhibitors/pharmacology , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism , Signal Transduction/drug effects , Signal Transduction/physiology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...